Related Experiment Video
Updated: May 17, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Idiopathic pulmonary fibrosis.
Jason S Zolak1, Joao A de Andrade
1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Boulevard, THT 422, Birmingham, AL 35294-0006, USA.
Immunology and Allergy Clinics of North America
|October 30, 2012
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive lung scarring disease with unpredictable outcomes. Current treatments focus on preserving lung function and quality of life, as no FDA-approved therapies improve survival.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by irreversible scarring of lung tissue.
- The exact cause of IPF remains unknown, leading to relentless decline in lung function.
Purpose of the Study:
- To summarize the current understanding of Idiopathic Pulmonary Fibrosis (IPF).
- To highlight diagnostic challenges and the lack of effective therapies.
- To recommend supportive care strategies for patients with IPF.
Main Methods:
- Review of existing literature and clinical trial data on IPF.
- Analysis of diagnostic approaches involving multidisciplinary teams.
- Evaluation of current management strategies and supportive care.
Main Results:
- Diagnosis of IPF requires integrated expertise from clinicians, radiologists, and pathologists.
- The clinical trajectory of IPF is highly unpredictable.
- No Food and Drug Administration (FDA)-approved therapies currently exist to improve survival in IPF patients.
Conclusions:
- Management of IPF should prioritize measures to maintain lung function and enhance quality of life.
- Aggressive treatment of gastroesophageal reflux is recommended for IPF patients.
- Further research is needed to develop therapies that can alter the course of IPF and improve survival.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...